Result card

  • SOC2: Who are the important others that may be affected, in addition to the individual using IGG?
English
No adaptation help available for this domain

Who are the important others that may be affected, in addition to the individual using IGG?

Authors: Alessandra Lo Scalzo, Cristina Mototolea, Ingrid Wilbacher

Internal reviewers: Pseudo253 Pseudo253, Pseudo340 Pseudo340

The technology under assessment is still in its early stage of development and evidence based answers to the AEs of SOC domain we selected during the protocol, cannot be given.

Lo Scalzo A et al. Result Card SOC2 In: Lo Scalzo A et al. Social aspects In: Jefferson T, Cerbo M, Vicari N [eds.]. Use of Intravenous immunoglobulins for Alzeheimer’s disease including Mild Cognitive Impairment [Core HTA], Agenas - Agenzia nazionale per i servizi sanitari regionali ; 2015. [cited 30 October 2020]. Available from: http://corehta.info/ViewCover.aspx?id=267